Entia Financial Statements From 2010 to 2025
| ERGO Stock | USD 0.0001 0.00 0.00% |
Check Entia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entia Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Entia financial statements analysis is a perfect complement when working with Entia Biosciences Valuation or Volatility modules.
Entia |
Entia Biosciences Company Shares Outstanding Analysis
Entia Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Entia Biosciences Shares Outstanding | 33.66 M |
Most of Entia Biosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entia Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Entia Biosciences has 33.66 M of shares currently outstending. This is 81.35% lower than that of the Healthcare sector and 68.5% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 94.11% higher than that of the company.
Entia Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entia Biosciences's current stock value. Our valuation model uses many indicators to compare Entia Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entia Biosciences competition to find correlations between indicators driving Entia Biosciences's intrinsic value. More Info.Entia Biosciences is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Entia Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Entia Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Entia Biosciences Financial Statements
Entia Biosciences investors utilize fundamental indicators, such as revenue or net income, to predict how Entia Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Pair Trading with Entia Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Entia Pink Sheet
| 0.65 | NVO | Novo Nordisk AS | PairCorr |
| 0.64 | NONOF | Novo Nordisk AS Downward Rally | PairCorr |
| 0.76 | CSLLY | CSL | PairCorr |
Moving against Entia Pink Sheet
| 0.82 | LH | Laboratory | PairCorr |
| 0.73 | RSLBF | RaySearch Laboratories | PairCorr |
| 0.69 | UBER | Uber Technologies | PairCorr |
| 0.6 | LAUR | Laureate Education | PairCorr |
| 0.59 | IBM | International Business | PairCorr |
The ability to find closely correlated positions to Entia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entia Biosciences to buy it.
The correlation of Entia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.